| Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study A Spanu, S Nuvoli, A Marongiu, I Gelo, L Mele, B Piras, G Madeddu BMC cancer 20, 1-10, 2020 | 26 | 2020 |
| Personalized dosimetry in the context of radioiodine therapy for differentiated thyroid cancer M Pacilio, M Conte, V Frantellizzi, MS De Feo, AR Pisani, A Marongiu, ... Diagnostics 12 (7), 1763, 2022 | 12 | 2022 |
| The Diagnostic Usefulness of 131I-SPECT/CT at Both Radioiodine Ablation and during Long-Term Follow-Up in Patients Thyroidectomized for Differentiated … A Spanu, S Nuvoli, A Marongiu, I Gelo, L Mele, A De Vito, M Rondini, ... Diagnostics 11 (8), 1504, 2021 | 12 | 2021 |
| Patient‐reported pain severity and health‐related quality of life in patients with multiple myeloma in real world clinical practice H Ludwig, AL Bailey, A Marongiu, K Khela, G Milligan, KB Carlson, ... Cancer Reports 5 (1), e1429, 2022 | 10 | 2022 |
| Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in Europe R von Moos, K Lewis, L Massey, A Marongiu, A Rider, A Seesaghur Bone 154, 116243, 2022 | 10 | 2022 |
| Physical, emotional and social pain communication by patients diagnosed and living with multiple myeloma B Quinn, H Ludwig, A Bailey, K Khela, A Marongiu, KB Carlson, A Rider, ... Pain management 12 (1), 59-74, 2021 | 10 | 2021 |
| Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study L Filippi, V Frantellizzi, F Monari, E Lodi Rizzini, E Tabacchi, R Pirisino, ... Diagnostics 11 (7), 1264, 2021 | 7 | 2021 |
| Risk of infections and mortality in Danish patients with cancer diagnosed with bone metastases: a population-based cohort study TJ Hjelholt, TB Rasmussen, A Seesaghur, RK Hernandez, A Marongiu, ... BMJ open 11 (12), e049831, 2021 | 5 | 2021 |
| A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves’ Disease A Marongiu, S Nuvoli, A De Vito, M Rondini, A Spanu, G Madeddu Diagnostics 12 (11), 2801, 2022 | 3 | 2022 |
| Pet-radiomics in lymphoma and multiple myeloma: update of current literature L Filippi, C Ferrari, S Nuvoli, F Bianconi, D Donner, A Marongiu, ... Clinical and Translational Imaging 12 (2), 119-135, 2024 | 2 | 2024 |
| Hashimoto’s Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor A Marongiu, S Nuvoli, A De Vito, S Vargiu, A Spanu, G Madeddu Diagnostics 13 (19), 3068, 2023 | 2 | 2023 |
| Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule F Corica, MS De Feo, ML Stazza, M Rondini, A Marongiu, V Frantellizzi, ... Cancers 15 (4), 1000, 2023 | 2 | 2023 |
| Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and … S Nuvoli, F Bianconi, M Rondini, A Lazzarato, A Marongiu, ML Fravolini, ... Diagnostics 12 (10), 2425, 2022 | 2 | 2022 |
| Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography … F Bianconi, R Salis, ML Fravolini, MU Khan, M Minestrini, L Filippi, ... Sensors 23 (18), 7952, 2023 | 1 | 2023 |
| Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study MS De Feo, V Frantellizzi, N Locuratolo, A Di Rocco, A Farcomeni, ... Life 13 (8), 1786, 2023 | 1 | 2023 |
| First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic … MMA Sidrak, MS De Feo, V Frantellizzi, A Marongiu, S Caponnetto, ... Cancer Biotherapy & Radiopharmaceuticals 38 (4), 232-245, 2023 | 1 | 2023 |
| The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study MS De Feo, V Frantellizzi, M Bauckneht, A Farcomeni, L Filippi, EL Rizzini, ... Biomedicines 11 (4), 1103, 2023 | 1 | 2023 |
| Breast-Specific gamma imaging: An added value in the diagnosis of breast cancer, a systematic review MS De Feo, MMA Sidrak, M Conte, V Frantellizzi, A Marongiu, ... Cancers 14 (19), 4619, 2022 | 1 | 2022 |
| Adherence to ESMO 2014 guidelines on bone-targeting agent (BTA) initiation for breast and prostate cancer patients: real-world insights from practicing European physicians A Rider, A Seesaghur, K Lewis, D Bluff, A Marongiu, G Demonty Annals of Oncology 30, v730-v731, 2019 | 1 | 2019 |
| Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term … A Marongiu, S Nuvoli, A De Vito, S Vargiu, A Spanu, G Madeddu Biomedicines 12 (2), 350, 2024 | | 2024 |
